Cancer stem cells sensitivity assay (STELLA) in patients with advanced lung and colorectal cancer: A feasibility study

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  D'Arcangelo, Manolo ^a   Todaro, Matilde ^b   Salvini, Jessica ^a   Benfante, Antonina ^b   Colorito, Maria Luisa ^b   D'Incecco, Armida ^a   Landi, Lorenza ^a   Apuzzo, Tiziana ^b   Rossi, Elisa ^c   Sani, Spartaco ^a   Stassi, Giorgio ^b   Cappuzzo, Federico ^a  

^a ISTITUTO TOSCANO TUMORI   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c Fondazione Ricerca Traslazionale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AFATINIB; CARBOPLATIN; CETUXIMAB; CISPLATIN; CRIZOTINIB; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ERLOTINIB; ETOPOSIDE; EVEROLIMUS; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; NAVELBINE; NILOTINIB; OXALIPLATIN; PACLITAXEL; PEMETREXED; SORAFENIB; SUNITINIB; TEMOZOLOMIDE; TOPOTECAN; TRASTUZUMAB; ANTINEOPLASTIC AGENT; DRUG COMBINATION;

ADVANCED CANCER; ARTICLE; CANCER STEM CELL; CELL ISOLATION; CLINICAL ARTICLE; COLORECTAL CANCER; DRUG SENSITIVITY; FEASIBILITY STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER METASTASIS; LUNG CANCER; LUNG NODULE; LYMPH NODE METASTASIS; PERICARDIAL EFFUSION; PLEURA EFFUSION; PROTEIN EXPRESSION; AGED; CELL SEPARATION; CLINICAL TRIAL; COLORECTAL TUMOR; DRUG COMBINATION; DRUG EFFECTS; DRUG SCREENING; FEMALE; LIVER TUMOR; LUNG TUMOR; MALE; MIDDLE AGED; PATHOLOGY; PROCEDURES; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CELL SEPARATION; COLORECTAL NEOPLASMS; DRUG COMBINATIONS; DRUG SCREENING ASSAYS, ANTITUMOR; FEASIBILITY STUDIES; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; PLEURAL EFFUSION; TIME FACTORS;

EID: 84957099292     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125037     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90. doi: 10.3322/caac.20107 PMID: 21296855
2. Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell. 2006;127(4):679-695. PMID: 17110329
3. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12(8):895-904. PMID: 16892035
4. Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, Saijo N, etal. Gefitiniborcarboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009;361(10):947-957. doi: 10.1056/NEJMoa0810699 PMID: 19692680
5. Van Cutsem E, Köhne CH, Láng I, Folprecht G, Nowacki MP, Cascinu S, etal. Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status. J Clin Oncol. 2011;29(15):2011-2019. doi: 10.1200/JCO.2010.33.5091 PMID: 21502544
6. Balduzzi S, Mantarro S, Guarneri V, Tagliabue L, Pistotti V, Moja L, et al. Trastuzumab-containing regimens for metastatic breast cancer. Cochrane Database Syst Rev. 2014;6:CD006242. doi: 10.1002/14651858. CD006242.pub2 PMID: 24919460
7. Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naïve patients with advanced-stage non-small-cell lung cancer. J Clin Oncol. 2008;26(21):3543-3551. doi: 10.1200/JCO.2007.15.0375 PMID: 18506025
8. Valent P, Bonnet D, De Maria R, Lapidot T, Copland M, Melo GV, etal. Cancer stem cell definitions and terminology: the devil is in the details. Nat Rev Cancer. 2012;12(11):767-775 doi: 10.1038/nrc3368 PMID: 23051844
9. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts. Ann Rev Med. 2007;58:267-284. PMID: 17002552
10. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science. 1997;197(4306):893-895.
11. Heppner GH. Tumor heterogeneity. Cancer Res. 1984;44(6):2259-2265. PMID: 6372991
12. Nowell PC. Mechanisms of tumor progression. Cancer Res. 1986;46(5):2203-2207. PMID: 3516380
13. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105-111. PMID: 11689955
14. Nowell PC. The clonal evolution of tumor cell populations. Science. 1997;194(4260):23-28.
15. Graves M, Maley CC. Clonal evolution in cancer. Nature. 2012;481(7381):306-313. doi: 10.1038/nature10762 PMID: 22258609
16. Notta F, Mullighan CG, Wang JC, Poeppl A, Doulatov S, Phillips LA, etal. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature. 2011;469(7330):362-367. doi: 10.1038/nature09733 PMID: 21248843
17. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3(7):730-737. PMID: 9212098
18. Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res. 2004;6(6):R605-R615. PMID: 15535842
19. Lombardo Y, Scopelliti A, Cammareri P, Todaro M, Iovino F, Ricci-Vitiani L, etal. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology. 2011;140(1):297-309. doi: 10.1053/j.gastro.2010.10.005 PMID: 20951698
20. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, etal. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature. 2010;468(7325):824-828. doi: 10. 1038/nature09557 PMID: 21102434
21. Bapat SA, Mali AM, Koppikar CB, Kurrey NK. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res. 2005;65(8):3025-3029. PMID: 15833827
22. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, etal. Atumorigenicsubpopulation with stem cell properties in melanomas. Cancer Res. 2005;65(20):9328-9337. PMID: 16230395
23. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, etal. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A. 2009;106(38):16281-16286. doi: 10.1073/pnas.0905653106 PMID: 19805294
24. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, etal. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008;15(3):504-514. PMID: 18049477
25. Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, etal. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cells. 2007;1(4):389-402. doi: 10.1016/j.stem.2007.08.001 PMID: 18371377
26. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, etal. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007;445(7123):111-115. PMID: 17122771
27. Mancini R, Giarnieri E, De Vitis C, Malanga D, Roscilli G, Noto A, et al. Spheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftment. PLoS One. 2011;6(7):e21320. doi: 10.1371/journal.pone.0021320 PMID: 21789168
28. Maugeri-Saccà M, Vigneri P, De Maria R. Cancer stem cells and chemosensitivity. Clin Cancer Res. 2011;17:4942-4947. doi: 10.1158/1078-0432. CCR-10-2538 PMID: 21622723
29. An Y, Ongkeko WM. ABCG2: the key to chemoresistance in cancer stem cells? Expert Opin Drug Metab Toxicol. 2009;5(12):1529-1542. doi: 10.1517/17425250903228834 PMID: 19708828
30. Ho MM, Ng AV, Lam S, Hung JY. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 2007;67(10):4827-4833. PMID: 17510412
31. Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, etal. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst. 2008;100:672-679. doi: 10.1093/jnci/djn123 PMID: 18445819
32. Tachezy M, Zander H, Wolters-Eisfeld G, Müller J, Wicklein D, Gebauer F, etal. Activated leukocyte cell adhesion molecule (CD166); An 'Inert' cancer stem cell marker for non-small cell lung cancer? Stem Cells. 2014;32(6):1429-36. doi: 10.1002/stem.1665 PMID: 24501004
33. Chen YC, Hsu HS, Chen YW, Tsai TH, How CK, Wang CY, et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLOS One. 2008;3(7):e2637. doi: 10.1371/journal.pone.0002637 PMID: 18612434
34. Mironova EV, Evstratova AA, Antonov SM. A fluorescence vital assay for the recognition and quantification of excitotoxic cell death by necrosis and apoptosis using confocal microscopy on neurons in culture. J Neurosci Methods. 2007;163(1):1-8. PMID: 17395268